ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IGC IGC Pharma Inc

0.48
0.05 (11.63%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
IGC Pharma Inc IGC AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 11.63% 0.48 18:51:12
Open Price Low Price High Price Close Price Previous Close
0.421 0.417551 0.496 0.458 0.43
more quote information »

Recent News

Date Time Source Heading
4/16/202406:00BWIGC-AD1’s Interim Phase 2 Data Show a Reduction in..
4/09/202408:00BWIGC Pharma Adds Advisor in Artificial Intelligence
3/26/202414:00BWIGC Pharma Announces $3 Million Unregistered Private..
3/20/202410:00BWIGC Pharma Announces Positive Interim Results for IGC-AD1 in..
3/20/202406:00BWIGC PHARMA Announces its Participation at the Benzinga..
3/12/202414:00BWIGC Pharma (IGC): Healthcare Leader Terry Lierman Joins..
2/28/202412:00BWPromising Results: TGR-63 Enhances Memory in Alzheimer's..
2/23/202411:01BWIGC Pharma Announces Equity Analyst Coverage by Ascendiant..
2/16/202418:05BWIGC Pharma Reports Third Quarter Fiscal 2024 Results
2/14/202415:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/01/202408:20BWIGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's..
1/31/202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/23/202408:20BWIGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63..
1/17/202408:20BWIGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing..
1/08/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
12/29/202315:54EDGAR2Form S-3 - Registration statement under Securities Act of..
12/19/202308:20BWPatent Granted to IGC Pharma for Groundbreaking Drug..
12/13/202308:30BWIGC Pharma Announces Participation in Biotech Showcase and..
12/06/202307:30BWIGC Pharma Announces Collaboration to Integrate AI into..
11/21/202307:30BWIGC Pharma Announces Master Agreement with Leading South..
11/13/202307:00BWIGC Pharma Reports Second Quarter Fiscal 2024 Results
11/09/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/27/202316:21EDGAR2Form 8-K - Current report
10/27/202315:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/19/202314:30BWIGC Pharma Granted European Patent for Groundbreaking..
9/29/202316:23EDGAR2Form S-3 - Registration statement under Securities Act of..
8/21/202313:30BWIGC Announces Results of its 2023 Annual Stockholders..
8/21/202311:44EDGAR2Form 8-K - Current report
8/14/202307:30BWIGC Pharma Reports First Quarter Results; Company Continues..
8/10/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/202307:30BWIGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the..
7/26/202316:26EDGAR2Form DEF 14A - Other definitive proxy statements
7/18/202304:22BWIGC Pharma, Inc. Presenting 6 Posters on the Positive Impact..
7/12/202307:44BWIGC Reports Financial Results for Fiscal Year Ended March..
7/07/202315:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
7/07/202310:41EDGAR2Form 8-K - Current report
7/07/202308:15BWIGC Pharma Secures $12 Million Line of Credit from O-Bank..
7/06/202306:46BWIGC Pharma Announces a $3 Million Private Placement of its..
6/30/202315:03EDGAR2Form NT 10-K - Notification of inability to timely file Form..
6/28/202320:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202312:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202308:20BWIGC Pharma Receives Notice of Allowance for Patent on..
6/05/202307:30BWIGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63..

Your Recent History

Delayed Upgrade Clock